Advanced Biomedical Technologies Inc (ABMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2022 | 10-2021 | 10-2020 | 10-2019 | 10-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 37 | 202 | 6 | 7 |
| Receivables | 40 | 76 | 29 | 50 | 33 |
| Inventories | 248 | 189 | 100 | 64 | N/A |
| TOTAL | $293 | $302 | $331 | $120 | $40 |
| Non-Current Assets | |||||
| PPE Net | 103 | 140 | 106 | 99 | 103 |
| Other Non-Current Assets | 0 | 7 | 33 | 0 | 0 |
| TOTAL | $103 | $147 | $138 | $99 | $103 |
| Total Assets | $396 | $449 | $469 | $219 | $142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,332 | 8,826 | 7,836 | 6,697 | 5,761 |
| TOTAL | $8,332 | $8,833 | $7,864 | $6,697 | $5,761 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,332 | $8,833 | $7,864 | $6,697 | $5,761 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,905 | 70,605 | 70,225 | 69,975 | 69,625 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -11,501 | -10,986 | -10,256 | -9,581 | -8,633 |
| Other shareholders' equity | 661 | -270 | 30 | 334 | 273 |
| TOTAL | $-7,936 | $-8,384 | $-7,402 | $-6,478 | $-5,619 |
| Total Liabilities And Equity | $396 | $449 | $462 | $219 | $142 |